Equity Profile

EW

Edwards Lifesciences Corporation

Health CareHealth Care Equipment$52.9B

Jul23Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Edwards Lifesciences Corporation (EW) is a leader in heart valve therapies and hemodynamic monitoring. The company plays a crucial role in the healthcare sector by providing innovative solutions that improve patient outcomes in cardiovascular care.

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of profitability and will help gauge the company's financial health this quarter.

N/A

Revenue Growth

Revenue growth is essential to assess how well the company is expanding its market presence and meeting demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

EW Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+87.79%

Avg Stock Reaction

-0.42%

Last Quarter Recap

In Q1-2026, Edwards Lifesciences reported an EPS of $0.78, exceeding expectations by 7.59%. However, the stock fell by 2.22% the following day, indicating mixed market reactions.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Edwards Lifesciences are cautious, given the mixed performance in recent quarters. Investors are looking for signs of consistent growth and profitability.

Bull Case

If the company can demonstrate strong revenue growth and maintain or exceed its EPS from the last quarter, it could signal a robust recovery and increased investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of declining sales, it could lead to further stock price pressure.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter?

EPS is a critical measure of profitability, and any significant deviation from expectations could impact investor sentiment.

How is revenue growth trending in key markets?

Understanding revenue trends will help assess the company's ability to capture market share and drive future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth driven by new product launches in the cardiovascular space.

Supporting Evidence

Recent product innovations have not been fully factored into revenue projections.

The company's strong historical EPS beat rate suggests it may outperform expectations again.

Key Risk

If revenue growth comes in significantly above expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial for validating the company's growth trajectory and market position.

Bull Confirmed If

An EPS of $0.80 or higher would confirm strong underlying performance.

Bear Confirmed If

An EPS below $0.75 would raise concerns about profitability and growth.

Pre-Earnings Positioning

Options Market

Implied Move

±5.93%

Historical Avg

±0.7%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±5.9% while EW has averaged ±0.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

32.1%

Calls (397K)P/C Ratio: 0.49Puts (340K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Edwards beats expectations, history suggests the stock could rise by approximately 0.74%, confirming a positive outlook.

In-Line / Cautious

If results are in line but management provides cautious commentary, the stock may experience minimal movement as investors reassess.

Miss

A miss could lead to a decline of around 0.33%, reflecting disappointment in the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on market conditions and competitive landscape.
3Details on cost management strategies and their effect on margins.
4Insights into international market performance and growth opportunities.
5Any changes in guidance or outlook for the remainder of the fiscal year.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Calix, Inc.

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of profitability and will help gauge the company's financial health this quarter.

N/A

Revenue Growth

Revenue growth is essential to assess how well the company is expanding its market presence and meeting demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

EW Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+87.79%

Avg Stock Reaction

-0.42%

Last Quarter Recap

In Q1-2026, Edwards Lifesciences reported an EPS of $0.78, exceeding expectations by 7.59%. However, the stock fell by 2.22% the following day, indicating mixed market reactions.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Edwards Lifesciences are cautious, given the mixed performance in recent quarters. Investors are looking for signs of consistent growth and profitability.

Bull Case

If the company can demonstrate strong revenue growth and maintain or exceed its EPS from the last quarter, it could signal a robust recovery and increased investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of declining sales, it could lead to further stock price pressure.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter?

EPS is a critical measure of profitability, and any significant deviation from expectations could impact investor sentiment.

How is revenue growth trending in key markets?

Understanding revenue trends will help assess the company's ability to capture market share and drive future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth driven by new product launches in the cardiovascular space.

Supporting Evidence

Recent product innovations have not been fully factored into revenue projections.

The company's strong historical EPS beat rate suggests it may outperform expectations again.

Key Risk

If revenue growth comes in significantly above expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial for validating the company's growth trajectory and market position.

Bull Confirmed If

An EPS of $0.80 or higher would confirm strong underlying performance.

Bear Confirmed If

An EPS below $0.75 would raise concerns about profitability and growth.

Pre-Earnings Positioning

Options Market

Implied Move

±5.93%

Historical Avg

±0.7%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±5.9% while EW has averaged ±0.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

32.1%

Calls (397K)P/C Ratio: 0.49Puts (340K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Edwards beats expectations, history suggests the stock could rise by approximately 0.74%, confirming a positive outlook.

In-Line / Cautious

If results are in line but management provides cautious commentary, the stock may experience minimal movement as investors reassess.

Miss

A miss could lead to a decline of around 0.33%, reflecting disappointment in the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on market conditions and competitive landscape.
3Details on cost management strategies and their effect on margins.
4Insights into international market performance and growth opportunities.
5Any changes in guidance or outlook for the remainder of the fiscal year.